Plasmacytoid dendritic cells (pDC) primarily function as weak antigen-presenting cells (APC), but have also been shown to ...
Healthcare Asia on MSN7 小时
Challenges remain in treating T2-low asthma
Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...
Metabolites—small molecules within cells, biofluids, tissues or organisms—play an integral role in various diseases, and ...
A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.
Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...
Allergies affect millions of people in Singapore, impacting daily life and overall well-being. Identifying allergens through ...
INR:6225. powerful football team names Innovent Biologics' PD-1 third indication marketing application accepted! Second-line treatment of squamous NS ...
betmgm 12 digit promo code for existing users Novartis' next-generation IgE antibody therapy receives FDA breakthrough therapy designation Astellas files for new indication for Xtandi in metastatic ...
INR:4121. winning slots casino The issue of village doctors is being addressed locally, and treatment is being improved through various means. Novartis' next ...
INR:9812. bet365 s Single-cell atlas reveals drug resistance mechanism in ulcerative colitis Merck's new HIV drug applies for listing in China Novartis' next-generation ...
H.C. Wainwright upgraded Rapt Therapeutics (RAPT) to Buy from Neutral with a $10 price target after Rapt and a subsidiary of ...
Leerink Partners analyst Thomas Smith has maintained their neutral stance on RAPT stock, giving a Hold rating on December 12.Don't Miss Our ...